Chief Discovery Officer · MapLight Therapeutics, Inc. · Voting Common Stock
Side
SELL
Value
$242K
Shares
8,346
Price
$28.96
Executed
Apr 27, 2026
Disclosed
Apr 29, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 27 executedApr 29, 2026 disclosed
MPLT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+15 / 15
5 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kreitzer Anatol filed this Form 4 reporting a open-market sale of MPLT on Apr 27, 2026. It became public on Apr 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Discovery Officer
Kreitzer Anatolcik:0002021238
Issuer
MapLight Therapeutics, Inc.cik:0001770069
Revision history · 0
No field has changed since this record was first ingested.
